Atomera reported limited revenue of about USD 65,000 for FY 2025, primarily from MSTcad licensing and related consulting services, and engineering services from the delivery of MST wafers. Cost of revenue was about USD 321,000 in FY 2025. Operating expenses totaled about USD 20.9 million in FY 2025, including R&D expense of about USD 12.3 million (+12%) and G&A expense of about USD 7.8 million (+7%), while selling and marketing expense was about USD 758,000 (-28%). Atomera posted a net loss of about USD 20.2 million for FY 2025. The company ended FY 2025 with cash and cash equivalents of about USD 19.2 million and working capital of about USD 17.6 million, and said it expects its available working capital, after a February 2026 registered direct offering, to fund forecasted needs for at least the next 24 months. Atomera also highlighted equity financings, including about USD 7.6 million of net proceeds from selling about 1.6 million shares via its at-the-market facilities during FY 2025, and net proceeds of about USD 23.6 million from a February 2026 registered direct offering of 5,000,000 shares at USD 5.00 per share.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atomera Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-001291), on February 24, 2026, and is solely responsible for the information contained therein.
Comments